Inventurus Knowledge Solutions, a leading healthcare technology company, has announced the price band for its much-awaited Initial Public Offering (IPO). The company is expected to attract strong interest from investors due to its promising growth prospects in the healthcare sector.
IPO Price Band and Subscription Dates
The price band for the Inventurus Knowledge Solutions IPO is set between ₹1,265 and ₹1,329 per share. The subscription window for the IPO will open on December 12, 2024, and close on December 16, 2024. Investors can apply for the IPO via brokers or online platforms. The minimum bid lot is 11 shares, and any subsequent bids must be in multiples of 11 shares.
The IPO is a book-built offering, meaning the final price within the given range will be decided based on demand from investors. It is also important to note that the price range is 1,265 times to 1,329 times the face value of the equity shares, which is Re 1 per share.
IPO Size and Offer for Sale
Inventurus Knowledge Solutions is offering 1.88 crore shares in its IPO, with the entire offering being a part of the offer-for-sale (OFS) segment. This means that the shares being sold in the IPO are being offered by the existing shareholders of the company.
The IPO size is ₹2,497.92 crore, making it a significant listing in the Indian stock market.
Investor Allocation
The IPO will be divided into different categories for investor allocation:
- Qualified Institutional Buyers (QIBs): 75% of the shares will be allocated to QIBs, which include institutional investors such as mutual funds and insurance companies.
- Non-Institutional Investors (NIIs): 15% of the shares will be reserved for high-net-worth individuals and other non-institutional investors.
- Retail Investors: 10% of the shares will be available for retail investors, allowing individual investors to participate in the IPO.
Before the IPO opens for subscription, the company plans to allocate shares to anchor investors on December 11, 2024. Anchor investors are usually large institutional investors who show interest in the IPO before it opens to the public. This helps establish the initial indication of demand for the IPO.
The basis for share allotment will be finalized by December 17, 2024. Refunds will be processed on December 18, and the shares will be credited to the demat accounts of successful investors on the same day. The shares are anticipated to be listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on December 19, 2024.
Inventurus Knowledge Solutions (IKS Health), established in 2006, offers technology-driven services to healthcare organizations around the globe. The company specializes in administrative tasks, helping healthcare providers with functions such as medical coding, clinical support, and management of medical documentation.
IKS Health has a global client base, including pharmaceutical companies, biotechnology firms, and healthcare organizations. With the increasing demand for healthcare technology services, the company is well-positioned to grow in the coming years.
Currently, the grey market premium (GMP) for the Inventurus Knowledge Solutions IPO stands at ₹225. This means that shares of the company are being traded in the grey market at a premium of ₹225 over the IPO price, indicating strong investor demand. If the IPO is priced at the upper end of the range at ₹1,329, the estimated listing price of the shares could be ₹1,554, which is about 16.93% higher than the IPO price.
The grey market premium indicates the market’s interest in the company’s shares, reflecting a positive outlook for potential investors.
The upcoming Inventurus Knowledge Solutions IPO is expected to be a significant event in the Indian stock market. With a strong financial background, solid growth prospects, and a growing demand for healthcare technology services, the IPO is attracting considerable attention. Investors should carefully consider the details of the IPO, including the price band, share allocation, and company prospects, before making their investment decisions.
As always, it is recommended to consult with a financial advisor to assess the risks and benefits of investing in IPOs.
